스튜디오미르 주식 가격. 408900 - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

스튜디오미르 (408900)

0.00

0.00

( 0.00% )

업데이트: -

개인 투자자를 위한 전문가급 도구.

가격

-

매수가

-

매도가

-

거래량

-

0.00 일간 변동폭 0.00

0.00 52주 범위 0.00

전일 종가

-

개장가

-

최근 거래 시간

마지막 거래 시간

-

평균 볼륨(3m)

-

재정 규모

-

VWAP

-

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form ARS - Annual Report to Security Holders

Form DEF 14A - Other definitive proxy statements

Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial

PITTSBURGH, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us,” “we” or the “Company”), a clinical-stage biotechnology company addressing...

Form 8-K - Current report

Form 8-K - Current report

Lipella Pharmaceuticals Announces Closing of $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules

PITTSBURGH, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (“Lipella” or the “Company”) (Nasdaq: LIPO), a clinical-stage biotechnology company addressing serious diseases with...

Form 424B5 - Prospectus [Rule 424(b)(5)]

Lipella Pharmaceuticals Announces $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules

PITTSBURGH, Pa., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (“Lipella” or the “Company”) (Nasdaq: LIPO), a clinical-stage biotechnology company addressing serious diseases...

Form PRE 14A - Other preliminary proxy statements

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

가장 활성
% 상승자
% 패자

기호	가격	볼륨

fuagf

fuagf 57 초 전

Ah, photos of Trump i've seen lately haven't struck me either being more or less Cheeto looking. You would know better than i if any particular photos
have been doctored, or not. Take your point about dating them though i don't think it would get much traction, and to me he is as sick in

ducci1

ducci1 1 분 전

Pivot Calcs:----SPX Pivot--5416----R1--5455----R2--5475----R3--5514----S1--5395----S2--5355----S3--5335------SPY Pivot--540----R1--544----R2--546----R3--550----S1--538----S2--534----S3--532 !!

CassieW

CassieW 2 분 전

Let me just be one of the first to say:

CONGRATS ALL NWBO LONGS!

Bost

Very well said and I share the same thoughts. I really feel that JB conned Kevin or Kevin is working with JB on something. To put it bluntly it's just plain sketchy. They never give straight answers and we only get real info when they have to give it but will delay it as long as they can. It's all s

BasedOnFeels

BasedOnFeels 5 분 전

Who wins in this scam then? Leonite? They are down quite a bit from getting shares @ 005. Not a very toxic loan. Opposite of scammy.
Preferred series share owners cant sell until audited financials. Opposite of scammy.
No shares issued since Minkowitz change of control. Opposite of sc

leverage102

leverage102 8 분 전

#NSAV$$$Entertainment; go to the Circus and take pics of the elephants. NSAV THE GOLDEN TICKET $$$$

ENTERTAINM NSAV

ddls

ddls 11 분 전

Sales-Track showing steep 2024 sales declines for BioElectronics.
Show me the sales money first.

STOP PRETENDING BIEL is worth something.

RitonavirCYP3A4

RitonavirCYP3A4 14 분 전

Got a link to that document?

Steady_T

Steady_T 15 분 전

Gosh, I guess the many thousands of shares I have in a Vanguard account don't count.

Although, I can't claim any part of the Vanguard increase since I haven't bought any additional AVXL in that account in 2 years.

SkyTrader7

SkyTrader7 15 분 전

Lots of buyings end of day

breadman41

breadman41 21 분 전

I just don’t understand why people who own shares continue to bash the stock they own…..weird…..have a good night everyone. Catch ya on the flip side.

Tom turtles

Tom turtles 22 분 전

Still waiting for the INQR divy shares...whatever happened to that ?

norisknorewards

norisknorewards 22 분 전

Another, oh, what are they called?

Ahh, another "flipparoo" swing for the fences, bud.

tnc26

tnc26 26 분 전

I have not heard any new contracts but a lot of noise. When is the next financial report?

condor1

condor1 27 분 전

A reasonable question for someone who never does any research to get DD answers.
Here is the responsive research below:
Cautionary Note to U.S. Investors
Alamos prepares its disclosure in accordance with the requirements of securities laws in effect in Canada.
Unless

MasterBlastr

MasterBlastr 28 분 전

And they should step forward and disclose something.

pinkslipjunkie

pinkslipjunkie 30 분 전

Yeah...I think when we see the 440 million volume days it will be much more exciting.
Agreed! Just a few small trades on a day with a total volume of only 440,727 is nothing to worry about.

MasterBlastr

MasterBlastr 30 분 전

Thanks for that, RB. I should take a better stab at reading the Q. Will see where this all goes

Here 2 Learn

Here 2 Learn 31 분 전

Great stuff! Thank you for the update! Look forward to hearing more!

Acme Investments

Acme Investments 31 분 전

I would like to talk to you guys about pumps!! Everyone I know who trades the otc buys in!! The price rises then eventually retail runs out of money!! Then either the stock flatlines like the last one you left or it tanks from the owner selling shares!! Archive this post for future reference!! Lol!!

Rkramden

Rkramden 32 분 전

Must read

https://help.kinduct.com/s/article/All-MTi-Related-Documentation-Links

Ray_137

Ray_137 33 분 전

Smilin_B

Smilin_B 34 분 전

If Ubiquitech is James Ballas's failed "CannaZALL" CBD company that he drove into the ground ( never providing a formal explanation of what happened to the assets, the organization that held everything together, the client base etc) - due to over promising and not delivering, coupled with the fact h

nwtf

nwtf 34 분 전

When its been sub zero for 10 years the degree of subzero it doesnt really matter does it??????

akennedy_stocks

akennedy_stocks 39 분 전

스튜디오미르

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관